Drugs / BENTAMAPIMOD
BENTAMAPIMOD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01630252 | Jun 2012 → Sep 2013 | endometriosis | PregLem SA | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BENTAMAPIMOD | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545213 ↗ |
| Known as | AS602801 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545213 ↗ |
| Known as | PGL5001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01630252 ↗ |
| Action | Inhibit | “JNK inhibitor PGL5001” NCT01630252 ↗ |
| Modality | Small molecule | — CHEMBL3545213 ↗ |
| Route | Oral | “JNK inhibitor PGL5001 orally administered” NCT01630252 ↗ |